scholarly article | Q13442814 |
P356 | DOI | 10.1111/MYC.12212 |
P698 | PubMed publication ID | 24943384 |
P2093 | author name string | Carol A Kauffman | |
Billy Franks | |||
Alison G Freifeld | |||
David L Horn | |||
Mindy G Schuster | |||
Nkechi E Azie | |||
P2860 | cites work | Fusarium infections in immunocompromised patients | Q24685627 |
Fusarium infection: report of 26 cases and review of 97 cases from the literature | Q27014001 | ||
Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions | Q29399166 | ||
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections | Q31130694 | ||
Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing | Q31149815 | ||
Human fusariosis | Q33975373 | ||
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. | Q34151084 | ||
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. | Q35181927 | ||
Infections caused by Fusarium species | Q35622021 | ||
The challenge of managing fusariosis | Q35693680 | ||
Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay | Q35806844 | ||
Treating disseminated fusariosis: amphotericin B, voriconazole or both? | Q36808076 | ||
Contact lens-related Fusarium infection: case series experience in New York City and review of fungal keratitis | Q36997658 | ||
Fusarium infection in lung transplant patients: report of 6 cases and review of the literature | Q37114436 | ||
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. | Q38025819 | ||
Fusarium infection in hematopoietic stem cell transplant recipients | Q44883924 | ||
P433 | issue | 11 | |
P304 | page(s) | 652-658 | |
P577 | publication date | 2014-06-18 | |
P1433 | published in | Mycoses | Q1956531 |
P1476 | title | Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry | |
P478 | volume | 57 |
Q92156299 | Blood culture and antimicrobial susceptibility pattern of bacteria and fungi isolated from febrile neutropenic patients treated with chemotherapy at Taleghani hospital, Tehran |
Q40451792 | Burden of fungal infections in Qatar. |
Q64075702 | Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient |
Q54503425 | Disseminated fusariosis with endophthalmitis after skin trauma in acute lymphoblastic leukaemia. |
Q57745968 | FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging |
Q41733907 | Fatal disseminated infection with Fusarium petroliphilum. |
Q38786385 | Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature. |
Q35923853 | Fusarium ramigenum, a novel human opportunist in a patient with common variable immunodeficiency and cellular immune defects: case report |
Q26750950 | Fusarium: Molecular Diversity and Intrinsic Drug Resistance |
Q28354154 | Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 |
Q35916585 | Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience |
Q58418132 | Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach |
Q46789764 | Proximal subungual onychomycosis caused by Fusarium falciforme successfully cured with posaconazole. |
Q49257990 | Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern |
Q40357629 | Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. |
Q88748282 | Synthesis and Evaluation of a Series of Bis(pentylpyridinium) Compounds as Antifungal Agents |
Q39189670 | The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). |
Q26746016 | Therapeutic Drug Monitoring of Posaconazole: an Update |
Q38965488 | Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings |
Search more.